Entero Therapeutics's total assets for Q were $85.82M, a decrease of -0.54% from the previous quarter. ENTO total liabilities were $15.77M for the fiscal quarter, a 1.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.